US2097235A - Water-soluble neutral bi-metal complex compounds of aliphatic polyhydroxy monocarboxylic acids - Google Patents
Water-soluble neutral bi-metal complex compounds of aliphatic polyhydroxy monocarboxylic acids Download PDFInfo
- Publication number
- US2097235A US2097235A US612638A US61263832A US2097235A US 2097235 A US2097235 A US 2097235A US 612638 A US612638 A US 612638A US 61263832 A US61263832 A US 61263832A US 2097235 A US2097235 A US 2097235A
- Authority
- US
- United States
- Prior art keywords
- calcium
- water
- complex compounds
- acid
- neutral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000007935 neutral effect Effects 0.000 title description 24
- 150000002763 monocarboxylic acids Chemical class 0.000 title description 12
- 125000001931 aliphatic group Chemical group 0.000 title description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- 150000001875 compounds Chemical class 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 239000000243 solution Substances 0.000 description 23
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 16
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 16
- 229960005069 calcium Drugs 0.000 description 15
- 229910052791 calcium Inorganic materials 0.000 description 15
- 239000011575 calcium Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- 229910052751 metal Inorganic materials 0.000 description 14
- 239000002184 metal Substances 0.000 description 14
- 239000000843 powder Substances 0.000 description 14
- -1 metal complex compounds Chemical class 0.000 description 12
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 239000004227 calcium gluconate Substances 0.000 description 9
- 235000013927 calcium gluconate Nutrition 0.000 description 9
- 229960004494 calcium gluconate Drugs 0.000 description 9
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- 229910052742 iron Inorganic materials 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 229910052712 strontium Inorganic materials 0.000 description 7
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 7
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 6
- 239000000920 calcium hydroxide Substances 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 5
- 150000007514 bases Chemical class 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 4
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000174 gluconic acid Substances 0.000 description 4
- 235000012208 gluconic acid Nutrition 0.000 description 4
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 150000001342 alkaline earth metals Chemical class 0.000 description 3
- 235000011116 calcium hydroxide Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 159000000008 strontium salts Chemical class 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 229910052718 tin Inorganic materials 0.000 description 3
- 229910052720 vanadium Inorganic materials 0.000 description 3
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 3
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-MGCNEYSASA-N D-galactonic acid Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-MGCNEYSASA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 229910052787 antimony Inorganic materials 0.000 description 2
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 2
- HMJCIIKLTQFEEN-UHFFFAOYSA-N antimony calcium Chemical compound [Ca].[Sb] HMJCIIKLTQFEEN-UHFFFAOYSA-N 0.000 description 2
- 239000010953 base metal Substances 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- LEVCFENDVHJJLX-MLBGHZOFSA-J calcium iron(2+) (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate Chemical group O=C([C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)[O-].[Fe+2].[Ca+2].O=C([C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)[O-].O=C([C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)[O-].O=C([C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)[O-] LEVCFENDVHJJLX-MLBGHZOFSA-J 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical class [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229940099563 lactobionic acid Drugs 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 229910052746 lanthanum Inorganic materials 0.000 description 2
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- GOLCXWYRSKYTSP-UHFFFAOYSA-N Arsenious Acid Chemical compound O1[As]2O[As]1O2 GOLCXWYRSKYTSP-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- CZNVSLGYWMSMKE-OPDGVEILSA-K Ferric gluconate Chemical compound [Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O CZNVSLGYWMSMKE-OPDGVEILSA-K 0.000 description 1
- 229910017569 La2(CO3)3 Inorganic materials 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- PRSMTOHTFYVJSQ-UHFFFAOYSA-N [Ca].[Pb] Chemical compound [Ca].[Pb] PRSMTOHTFYVJSQ-UHFFFAOYSA-N 0.000 description 1
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- DAMJCWMGELCIMI-UHFFFAOYSA-N benzyl n-(2-oxopyrrolidin-3-yl)carbamate Chemical compound C=1C=CC=CC=1COC(=O)NC1CCNC1=O DAMJCWMGELCIMI-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002562 calcium glucoheptonate Drugs 0.000 description 1
- FATUQANACHZLRT-XBQZYUPDSA-L calcium;(2r,3r,4s,5r,6r)-2,3,4,5,6,7-hexahydroxyheptanoate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C([O-])=O FATUQANACHZLRT-XBQZYUPDSA-L 0.000 description 1
- UMRUNOIJZLCTGG-UHFFFAOYSA-N calcium;manganese Chemical compound [Ca+2].[Mn].[Mn].[Mn].[Mn] UMRUNOIJZLCTGG-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- BDAGIHXWWSANSR-NJFSPNSNSA-N hydroxyformaldehyde Chemical compound O[14CH]=O BDAGIHXWWSANSR-NJFSPNSNSA-N 0.000 description 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- NZPIUJUFIFZSPW-UHFFFAOYSA-H lanthanum carbonate Chemical compound [La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O NZPIUJUFIFZSPW-UHFFFAOYSA-H 0.000 description 1
- 229960001633 lanthanum carbonate Drugs 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 229940056932 lead sulfide Drugs 0.000 description 1
- 229910052981 lead sulfide Inorganic materials 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229910000018 strontium carbonate Inorganic materials 0.000 description 1
- QRVYVKGHSWMAJI-IYEMJOQQSA-L strontium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Sr+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O QRVYVKGHSWMAJI-IYEMJOQQSA-L 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- YPMOSINXXHVZIL-UHFFFAOYSA-N sulfanylideneantimony Chemical compound [Sb]=S YPMOSINXXHVZIL-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229910052716 thallium Inorganic materials 0.000 description 1
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000003606 tin compounds Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
Definitions
- the present invention relates to water-soluble complex compounds of aliphatic polyhydroxy monocarboxylic acids of iron and alkali-earth metals suitable for therapeutic use and to a process of preparing the same, said invention being a further development of the invention described and claimed in the copending U. S. application Ser. No. 500,434, filed December 5, 1930, which has issued as Patent No. 2,066,742.
- This patent generally describes complex compounds of metals with aliphatic polyhydroxy carboxylic acids, said complex compounds may contain alkali metal or nitrogen bases as neutralizing agents.
- complex compounds of particular therapeutic value hitherto not described are obtained, when in the production of neutral water-soluble complex compounds of aliphatic polyhydroxy monocarboxylic acids with base metals, the atomic number of which is at least 22, but which do not belong to the alkali or alkaline earth metal series, basic compounds of calcium or strontium or equivalents thereof as hereinafter stated are used for neutralization of the said metal complex compounds.
- base metals the atomic number of at least 22
- calcium or strontium to yield products, soluble in Water with a neutral reaction; this result is an advance in the preparation of media, especially for therapy by injection.
- the new metal complex compounds as compared with similar compounds already described, display in any cases the further advantage that they can be applied not only without causing irritation, but in contradistinction to the corresponding alkali metal or amine salts without involving pain as the result of subcutaneous injection.
- the oxide, hydroxide or salt of a metal of the type above specified can be caused to react with the solution of an aliphatic polyhydroxy monocarboxylic acid or of a watersoluble salt of such an acid with the addition of a quantity of a basic compound of calcium or strontium required for the formation of the neutral calcium or strontium salt of the metal complex compound.
- a basic compound of calcium or strontium required for the formation of the neutral calcium or strontium salt of the metal complex compound.
- the calcium or strontium salts of the aliphatic polyhydroxy monocarboxylic acids as starting materials.
- basic compounds of calcium or strontium can be used for example, the oxides,
- Suitable polyhydroxy monocarboxylic acids capable of forming complex compounds are particularly the aliphatic hydroxy monocarboxylic acids of at least 5 carbon atoms and containing at least 3 hydroxy groups bound to 3 adjoining carbon atoms.
- lactones of the polyhydroxy monocarboxylic acids is equivalent to the acids themselves, because it is known that these lactcnes are changed into their corresponding acids by the afore-mentioned neutralization.
- polyhydroxy monocarboxylic acid used in the appended claims is intended to include the lactones of these acids.
- the metals can be combined with the complexforming polyhydroxy monocarboxylic acids in different relative amounts, and it therefore appears that the reaction is not confined to stoichiometric proportions.
- the complex compounds formed may advantageously be separated by pouring the solution into an alcohol, preferably methyl alcohol, and washing the precipitate formed with an alcohol, for example, and about 80 t o-100% methyl alcohOl.
- composition of our new complex compounds may vary Within Wide limits and is not restricted to stoichiometric proportions. Moreover, particularlythose compounds which do not correspond to simple atomic proportions, often display especially good therapeutic properties. In this connection it may be emphasized that the purpose of the present invention is not to provide metal complex compounds. of a definite chemical composition which would be of a more scientific interest but to provide valuable medicinal media.
- the metal is bound in the new complex compounds in complex-like linkage. This follows from the fact that these metals are not precipitated by dilute caustic alkali lyes or dilute hydrochloric acid.
- the complex-like linkage of the metal, the solubility of the complex compounds in water with about neutral reaction and the simultaneous content of the complexly bound metal and of calcium or strontium are the important characteristics of our new products.
- the new compounds are white to colored powders, this depending on the-metal used for the complex compounds. These compounds decompose on heating without distinctly melting and yield neutral aqueous solutions which are suitable for injection purposes in the medicinal practice.
- the invention is further illustrated by the following examples but is not restricted thereto.
- the parts are by weight.
- Example 1.8.6 parts of calcium gluconate, 2.7 parts of crystallized ferric chloride (6H2O) and 40 ccs. of water are'heated until solution has occurred.
- the solution is boiled together with 2 parts of calcium carbonate until the evolution of carbon dioxide has ceased.
- the solution is filtered and the filtrate poured into'methylalcohol.
- a light yellow amorphous powder, readily soluble in water, is obtained in a good yield, possessing an iron content of about 8%.
- the composition of the calcium iron-gluconate corresponds approximately to the formula:
- the aqueous solution is not precipitated by means of dilute caustic soda; oxalic acid precipitates calcium oxalate.
- calcium carbonate can be replaced by calcium hydroxide as neutralizing agent.
- Example 2.-9.52 parts of anhydrous strontium gluconate; 2.7 parts of crystallized ferric chloride (6H2O) and 40 cos. of water are heated until solution has occurred and the solution is boiled with 3 parts of strontium carbonate until evolution oi'carbon dioxide has ceased.
- the solution is filtered and the filtrate poured into methylalcohol.
- a light yellow amorphous powder, readily soluble in water, is obtained in a good yield having an iron content of about 7.3%.
- the composition of the strontium iron-gluconate presumably corresponds to the formula:
- Example 3 Example 3.--A solution f'8.6 parts of calcium gluconate and 4 parts of ferrous chloride (ll-I20) in about 40 ccs., of water is neutralized with milk of lime and the filtrate is poured into methyl alcohol. After separation and drying a green amorphous powder is obtained, which is readily soluble in water.
- Example 4 A solution of 10'parts of calcium gluconate in about 60 cos. of water is boiled with 5 parts of .arsenious acid'until almost the whole is dissolved. The filtrate is poured into methylalcohol. After separation and drying a white non-hygroscopic powder'is obtained'ina good yield, which is readily soluble in water in contradistinction to the calcium gluconate used. The arseniccontent of the calcium arsenic-gluconate amounts to about 20%.
- calcium gluconate of vanadium can be prepared by treating vanadium tetroxide with calcium gluconate.
- Example 5.-8.6 grams of calcium gluconate are added to a solution of 2 grams of lanthanum carbonate in 20 ccs. of N-hydrochloric acid and 25 cos. of water after the evolution of carbon dioxide has ceased, then heated until solution has occurred and boiled with 2 grams of calcium carbonate and filtered. The clear solution is poured into methylalcohol, while stirring, the precipitate formed is filtered'by suction, Washed with methylalcohol'and ether and dried. The calcium lanthanum gluconate forms a white powder, readily soluble in water, of a lanthanum content of about Example 6.60 grams of, calcium gluconate are suspended in 250 cos. of water.
- the suspension is heated and a solution of 11.5 grams of antimony trichloride in a little methylalcohol is added. Then ZN-milk of lime is added until a neutral reaction has been attained, the solution is filtered and the still'hot filtrate is poured into methylalcohol, while stirring; the complex salt formed is filtered by suction, the mother liquor containing sodium chloride is advantageously washed out with 80% methylalcohol and the salt is dried in air.
- the calcium antimony-gluconate is obtained as a c'olorless powder, soluble in water with a neutral reaction, of an antimony con- "tent ofabout 11.5%.
- the aqueous solution remains clear on the addition of dilute hydrochloric acid or dilute caustic soda. Oxalic acid precipitates calcium oxalate, sulfuretted hydrogen precipitates'antimony sulfide from acid solution.
- Soluble calcium antimony complex salts can likewise be obtained when different proportions are used in the above example, for instance, 40 grams of calcium gluconate.
- soluble calcium antimony complex salts for example, of glucoheptonic acid.
- Example 7 A solution of 6 grams of gluconic acid, 2.7 grams of crystallized ferric chloride (GI-I20) and 1.7 grams of anhydrous calcium chloride in 20 cos. of water is neutralized with N- caustic soda. The solution is precipitated by pouring into methylalcohol. After separation and drying the calcium iron-gluconate of the probable formula is obtained as a light yellow powder, readily soluble in water with a neutral reaction. Oxalic acid precipitates calcium oxalate from the aqueous solution. In an analogous manner calcium manganese gluconate can be prepared.
- Example 9 To a solution of 36 grams of gluconic acid lactone and 18 grams of lead acetate in water ZN-milk of lime is added until the mix ture remains neutral. After standing for some time the solution is filtered and the calcium lead gluccnate formed is precipitated by pouring into methylalcohcl. The precipitate is separated and dried. A whitish powder which is readily soluble in water with neutral reaction is obtained. From the solution of the lead complex compound lead sulfide is precipitated by means of hydrogen sulfide, ammonium oxalate precipitates calcium oxalate. The content of lead amounts to about 17 per cent. When other quantities of the components are applied, products with another lead content with analogous properties are obtained.
- a complex compound may be obtained when glucoheptonic acid lactone is used as complex-forming starting component.
- Example 10 To a solution of 54 grams of gluconic acid lactone and 22 grams of stannous chloride in water 2N-milk of lime is added While heating on the water bath until the reaction of the mixture remains neutral. The mixture is then cooled, filtered, the calcium tin-gluconate formed is precipitated by pouring into methylalcohol, the precipitate is filtered with suction, washed and dried in vacuo. A whitish powder is obtained which is soluble in water with a neutral reaction. The content of tin amounts to about 13 per cent.
- Neutral complex compounds of iron with an aliphatic polyhydroxy monocarboxylic acid of at least 5 carbon atoms and containing at least 3 hydroxy groups bound to 3 adjacent carbon atoms said complex compounds being neutral by their content of an alkaline earth metal selected from the class consisting of calcium and strontium and being whitish powders, soluble in water with about neutral reaction.
- Neutral calcium ferric-gluconate being a white powder, containing about 8% of iron, being soluble in water with about neutral reaction.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Patented Oct. 26, 1937 UNITED STATES PATENT OFFICE WATER-SOLUBLE NEUTRAL BI-METAL COM- FLEX COMPOUNDS OF ALIPHATIC POLY- HYDROXY MONGCARBOXYLIC ACIDS York No Drawing. Application May 20, 1932, Serial No. 612,638. In Germany May 30, 1931 3 Claims.
The present invention relates to water-soluble complex compounds of aliphatic polyhydroxy monocarboxylic acids of iron and alkali-earth metals suitable for therapeutic use and to a process of preparing the same, said invention being a further development of the invention described and claimed in the copending U. S. application Ser. No. 500,434, filed December 5, 1930, which has issued as Patent No. 2,066,742.
This patent generally describes complex compounds of metals with aliphatic polyhydroxy carboxylic acids, said complex compounds may contain alkali metal or nitrogen bases as neutralizing agents.
In accordance with the present invention complex compounds of particular therapeutic value hitherto not described are obtained, when in the production of neutral water-soluble complex compounds of aliphatic polyhydroxy monocarboxylic acids with base metals, the atomic number of which is at least 22, but which do not belong to the alkali or alkaline earth metal series, basic compounds of calcium or strontium or equivalents thereof as hereinafter stated are used for neutralization of the said metal complex compounds. In this manner it becomes possible to combine compounds of the base metals of an atomic number of at least 22, with the exception of metals of the alkali or alkaline earth metal series, with calcium or strontium to yield products, soluble in Water with a neutral reaction; this result is an advance in the preparation of media, especially for therapy by injection. The new metal complex compounds, as compared with similar compounds already described, display in any cases the further advantage that they can be applied not only without causing irritation, but in contradistinction to the corresponding alkali metal or amine salts without involving pain as the result of subcutaneous injection.
The production of the new complex compounds is carried out by the customary methods. Thus, for example, the oxide, hydroxide or salt of a metal of the type above specified can be caused to react with the solution of an aliphatic polyhydroxy monocarboxylic acid or of a watersoluble salt of such an acid with the addition of a quantity of a basic compound of calcium or strontium required for the formation of the neutral calcium or strontium salt of the metal complex compound. In particular it is possible to employ the calcium or strontium salts of the aliphatic polyhydroxy monocarboxylic acids as starting materials. As basic compounds of calcium or strontium can be used for example, the oxides,
hydroxides or carbonates. The simultaneous'use of a calcium or strontium salt and a basic compound of the alkali metals has been found to be equivalent to the direct use of the basic compounds of calcium or strontium above indicated.
Suitable polyhydroxy monocarboxylic acids capable of forming complex compounds are particularly the aliphatic hydroxy monocarboxylic acids of at least 5 carbon atoms and containing at least 3 hydroxy groups bound to 3 adjoining carbon atoms. We prefer to use the acids obtainable by the oxidation of sugars for example, arabonic acid, the acid of the formula HOOC C (CH3) OH.CHOH.CHOH.CH2OH gluconic acid, galactonic acid and lactobionic acid, but also polyhydroxy monocarboxylic acids obtainable by other methods, for example, glucoheptonic acid and mannoheptonic acid may be advantageously employed. The use of lactones of the polyhydroxy monocarboxylic acids is equivalent to the acids themselves, because it is known that these lactcnes are changed into their corresponding acids by the afore-mentioned neutralization. For this {reason the term polyhydroxy monocarboxylic acid used in the appended claims is intended to include the lactones of these acids.
The metals can be combined with the complexforming polyhydroxy monocarboxylic acids in different relative amounts, and it therefore appears that the reaction is not confined to stoichiometric proportions.
In the examples mentioned below we have described the production of complex compounds of those metals which compounds are of especially high interest for the medicinal use in this combination, that is to say, iron, tin, antimony, lead. Furthermore arsenic, copper, lanthanum are also mentioned. In the same manner as described in the examples Water-soluble, neutral metal complex compounds of thallium, cobalt, manganese, titanium, vanadium, nickel and the likemay be prepared, displaying a similar behavior as the products described in the examples and being characterized by the metal used in each individual case. In each case it is essential that the final reaction of the complex compound is made about neutral. From the aqueous reaction mixture the complex compounds formed may advantageously be separated by pouring the solution into an alcohol, preferably methyl alcohol, and washing the precipitate formed with an alcohol, for example, and about 80 t o-100% methyl alcohOl. t
The composition of our new complex compounds may vary Within Wide limits and is not restricted to stoichiometric proportions. Moreover, particularlythose compounds which do not correspond to simple atomic proportions, often display especially good therapeutic properties. In this connection it may be emphasized that the purpose of the present invention is not to provide metal complex compounds. of a definite chemical composition which would be of a more scientific interest but to provide valuable medicinal media.
In view of the complicated composition of the new products proved by analysis weare not able to give structural formulae which would define the products of the present invention in a general and more easily visible manner. in order to indicate more clearly which types of compounds are presumably formed by the present process the following probable formula of one compound, that is the calcium ferric- III-gluconate may give some idea of our new products. In this case two atoms of trivalent iron are combined with hydroxyl groups of six molecules of gluconic acid, the carboxylic acid groups of which have been neutralized by three calcium atoms. The reaction is most probably performed according to the following equation In many cases complex compoundsof another composition have proved especially good properties, whereby the complex bound metal may be combined with the aliphatic polyhydroxy carboxylic acid in other proportions, the metal apparently being bound to the hydroxy groups of different molecules of the aliphatic polyhydroxy carboxylic acid in another proportion.
The metal is bound in the new complex compounds in complex-like linkage. This follows from the fact that these metals are not precipitated by dilute caustic alkali lyes or dilute hydrochloric acid. The complex-like linkage of the metal, the solubility of the complex compounds in water with about neutral reaction and the simultaneous content of the complexly bound metal and of calcium or strontium are the important characteristics of our new products.
The new compounds are white to colored powders, this depending on the-metal used for the complex compounds. These compounds decompose on heating without distinctly melting and yield neutral aqueous solutions which are suitable for injection purposes in the medicinal practice.
The invention is further illustrated by the following examples but is not restricted thereto. The parts are by weight.
Example 1.8.6 parts of calcium gluconate, 2.7 parts of crystallized ferric chloride (6H2O) and 40 ccs. of water are'heated until solution has occurred. The solution is boiled together with 2 parts of calcium carbonate until the evolution of carbon dioxide has ceased. The solution is filtered and the filtrate poured into'methylalcohol. A light yellow amorphous powder, readily soluble in water, is obtained in a good yield, possessing an iron content of about 8%. The composition of the calcium iron-gluconate corresponds approximately to the formula:
However, r
The aqueous solution is not precipitated by means of dilute caustic soda; oxalic acid precipitates calcium oxalate.
In the above described process calcium carbonate can be replaced by calcium hydroxide as neutralizing agent.
Example 2.-9.52 parts of anhydrous strontium gluconate; 2.7 parts of crystallized ferric chloride (6H2O) and 40 cos. of water are heated until solution has occurred and the solution is boiled with 3 parts of strontium carbonate until evolution oi'carbon dioxide has ceased. The solution is filtered and the filtrate poured into methylalcohol. A light yellow amorphous powder, readily soluble in water, is obtained in a good yield having an iron content of about 7.3%. The composition of the strontium iron-gluconate presumably corresponds to the formula:
, Example 3.--A solution f'8.6 parts of calcium gluconate and 4 parts of ferrous chloride (ll-I20) in about 40 ccs., of water is neutralized with milk of lime and the filtrate is poured into methyl alcohol. After separation and drying a green amorphous powder is obtained, which is readily soluble in water.
Example 4.A solution of 10'parts of calcium gluconate in about 60 cos. of water is boiled with 5 parts of .arsenious acid'until almost the whole is dissolved. The filtrate is poured into methylalcohol. After separation and drying a white non-hygroscopic powder'is obtained'ina good yield, which is readily soluble in water in contradistinction to the calcium gluconate used. The arseniccontent of the calcium arsenic-gluconate amounts to about 20%. Likewise calcium gluconate of vanadium can be prepared by treating vanadium tetroxide with calcium gluconate.
or with gluconic acid lactone and calcium hydroxide.
, Example 5.-8.6 grams of calcium gluconate are added to a solution of 2 grams of lanthanum carbonate in 20 ccs. of N-hydrochloric acid and 25 cos. of water after the evolution of carbon dioxide has ceased, then heated until solution has occurred and boiled with 2 grams of calcium carbonate and filtered. The clear solution is poured into methylalcohol, while stirring, the precipitate formed is filtered'by suction, Washed with methylalcohol'and ether and dried. The calcium lanthanum gluconate forms a white powder, readily soluble in water, of a lanthanum content of about Example 6.60 grams of, calcium gluconate are suspended in 250 cos. of water. The suspension is heated and a solution of 11.5 grams of antimony trichloride in a little methylalcohol is added. Then ZN-milk of lime is added until a neutral reaction has been attained, the solution is filtered and the still'hot filtrate is poured into methylalcohol, while stirring; the complex salt formed is filtered by suction, the mother liquor containing sodium chloride is advantageously washed out with 80% methylalcohol and the salt is dried in air. The calcium antimony-gluconate is obtained as a c'olorless powder, soluble in water with a neutral reaction, of an antimony con- "tent ofabout 11.5%. The aqueous solution remains clear on the addition of dilute hydrochloric acid or dilute caustic soda. Oxalic acid precipitates calcium oxalate, sulfuretted hydrogen precipitates'antimony sulfide from acid solution.
Soluble calcium antimony complex salts can likewise be obtained when different proportions are used in the above example, for instance, 40 grams of calcium gluconate.
In a similar manner can be produced soluble calcium antimony complex salts, for example, of glucoheptonic acid.
Example 7.A solution of 6 grams of gluconic acid, 2.7 grams of crystallized ferric chloride (GI-I20) and 1.7 grams of anhydrous calcium chloride in 20 cos. of water is neutralized with N- caustic soda. The solution is precipitated by pouring into methylalcohol. After separation and drying the calcium iron-gluconate of the probable formula is obtained as a light yellow powder, readily soluble in water with a neutral reaction. Oxalic acid precipitates calcium oxalate from the aqueous solution. In an analogous manner calcium manganese gluconate can be prepared.
Example 8.4.9 grams of anhydrous calcium glucoheptonate, 1.35 grams of crystallized ferric chloride and one gram of calcium carbonate are boiled in 20 cos. of water until the evolution of carbon dioxide has ceased. The solution is filtered and the calcium iron-glucoheptonate of the probable formula formed is precipitated by pouring into methylaicohol. After separation and drying the calcium iron-glucoheptonate forms a yellow powder which is readily soluble in water.
Example 9.To a solution of 36 grams of gluconic acid lactone and 18 grams of lead acetate in water ZN-milk of lime is added until the mix ture remains neutral. After standing for some time the solution is filtered and the calcium lead gluccnate formed is precipitated by pouring into methylalcohcl. The precipitate is separated and dried. A whitish powder which is readily soluble in water with neutral reaction is obtained. From the solution of the lead complex compound lead sulfide is precipitated by means of hydrogen sulfide, ammonium oxalate precipitates calcium oxalate. The content of lead amounts to about 17 per cent. When other quantities of the components are applied, products with another lead content with analogous properties are obtained.
In an analogous manner a complex compound may be obtained when glucoheptonic acid lactone is used as complex-forming starting component.
Example 10.To a solution of 54 grams of gluconic acid lactone and 22 grams of stannous chloride in water 2N-milk of lime is added While heating on the water bath until the reaction of the mixture remains neutral. The mixture is then cooled, filtered, the calcium tin-gluconate formed is precipitated by pouring into methylalcohol, the precipitate is filtered with suction, washed and dried in vacuo. A whitish powder is obtained which is soluble in water with a neutral reaction. The content of tin amounts to about 13 per cent.
In an analogous manner corresponding complex salts, for example, of tetravalent tin when starting with tetravalent tin compounds or of copper or of titanium with gluconic acid or glucoheptonic acid or lactobionic acid or galactonic acid are obtainable.
We claim:
1. Neutral complex compounds of iron with an aliphatic polyhydroxy monocarboxylic acid of at least 5 carbon atoms and containing at least 3 hydroxy groups bound to 3 adjacent carbon atoms, said complex compounds being neutral by their content of an alkaline earth metal selected from the class consisting of calcium and strontium and being whitish powders, soluble in water with about neutral reaction.
2. Neutral complex compounds of iron with an aliphatic polyhydroxy monocarboxylic acid of 5 to '7 carbon atoms and containing at least 3 hydroxy groups bound to three adjacent carbon atoms, said complex compounds being neutral by the content of calcium, being whitish powders, soluble in water with about neutral reaction.
3. Neutral calcium ferric-gluconate, being a white powder, containing about 8% of iron, being soluble in water with about neutral reaction.
HANS SCHMIDT. HEINRICH J UNG.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2097235X | 1931-05-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
US2097235A true US2097235A (en) | 1937-10-26 |
Family
ID=7984779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US612638A Expired - Lifetime US2097235A (en) | 1931-05-30 | 1932-05-20 | Water-soluble neutral bi-metal complex compounds of aliphatic polyhydroxy monocarboxylic acids |
Country Status (1)
Country | Link |
---|---|
US (1) | US2097235A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2890233A (en) * | 1952-10-13 | 1959-06-09 | Opfermann Adolf Christia Josef | Iron-containing organic compounds |
US2937973A (en) * | 1954-02-15 | 1960-05-24 | Jensen Salsbery Lab Inc | Milk fever treatment composition |
US4678854A (en) * | 1986-11-25 | 1987-07-07 | Zinpro Corporation | Cobalt complexes and their use as nutritional supplements |
US4705876A (en) * | 1985-12-31 | 1987-11-10 | Vsesojuznoe Nauchno-Proizvodstvennoe Obiedinenie Tselljuloznobumazhnoy Promyshlennosti | Process for preparing powder-like iron-sodium tartrate complex |
US4956188A (en) * | 1988-10-20 | 1990-09-11 | Zinpro Corporation | Copper complexes with alpha hydroxy organic acids and their use as nutritional supplements |
-
1932
- 1932-05-20 US US612638A patent/US2097235A/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2890233A (en) * | 1952-10-13 | 1959-06-09 | Opfermann Adolf Christia Josef | Iron-containing organic compounds |
US2937973A (en) * | 1954-02-15 | 1960-05-24 | Jensen Salsbery Lab Inc | Milk fever treatment composition |
US4705876A (en) * | 1985-12-31 | 1987-11-10 | Vsesojuznoe Nauchno-Proizvodstvennoe Obiedinenie Tselljuloznobumazhnoy Promyshlennosti | Process for preparing powder-like iron-sodium tartrate complex |
US4678854A (en) * | 1986-11-25 | 1987-07-07 | Zinpro Corporation | Cobalt complexes and their use as nutritional supplements |
US4956188A (en) * | 1988-10-20 | 1990-09-11 | Zinpro Corporation | Copper complexes with alpha hydroxy organic acids and their use as nutritional supplements |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2215429A (en) | Metal compounds of aliphatic polyhydroxy monocarboxylic acids and process of making them | |
US2097235A (en) | Water-soluble neutral bi-metal complex compounds of aliphatic polyhydroxy monocarboxylic acids | |
US1964696A (en) | Complex compound of metals with aliphatic polyhydroxy-carboxylic acids and process of making the same | |
US3091626A (en) | Method of making ferrous citrate | |
US2066742A (en) | Antimony compounds of polyhydroxy carboxylic acids and process of making them | |
DE1168441B (en) | Process for the production of a polyaminopolyacetic acid and its complex metal compounds | |
US1990442A (en) | Complex compound of metals with aliphatic polyhydric alcohols and process of preparing the same | |
US1693432A (en) | Therapeutically-active aromatic compound containing mercury in a lateral chain and process of making the same | |
DE642245C (en) | Process for the production of neutral soluble metal complex salts | |
Fargher et al. | The Chemotherapy of Antimony. Comparison of the Antimonyl Tartrates with the Organic Compounds of Antimony | |
US2117777A (en) | Double salts of calcium ascorbate with calcium salts of other polyhydroxy-mono-carboxylic acids and process of making them | |
US1485380A (en) | Therapeutic compound and process of producing the same | |
DE544500C (en) | Process for the preparation of aliphatic auromercaptocarboxylic acids | |
US1547698A (en) | Hermann vieth | |
AT155072B (en) | Process for the preparation of neutral soluble metal complex salts. | |
US3139447A (en) | Preparation of ferrous ferri-ethylenediamine-tetra-acetate and process | |
DE1270540B (en) | Process for the preparation of water-soluble complex compounds of aliphatic oxycarboxylic acids | |
DE673874C (en) | Process for the preparation of antimony complex compounds | |
US1954615A (en) | Antimony derivative of sulpharsphenamine | |
US2890233A (en) | Iron-containing organic compounds | |
DE488931C (en) | Process for the preparation of selenometal compounds of the aromatic series | |
Von Oettingen et al. | The Preparation and Constitution of Soluble Bismuth Sodium Citrate, and of the Intermediate Products | |
US3123486A (en) | Alkali metal metalates | |
US3020286A (en) | Calcium nicotinate iodide | |
DE526392C (en) | Process for the production of metal complex compounds |